The first oral weight-loss pill – clinically proven to help you lose up to 17% of your body weight. Expected to be available from August 2026.
Be first in line, ahead of everyone else. No commitment, no cost – and absolutely no needles.
No injections. No excuses.
The daily pill can deliver results comparable to the weekly injection – no needle, no hesitation, no refrigeration. Prescribed and supervised by Swiss specialists.
Ten seconds each morning – that's it.
Take it once a day and carry on. No preparation, no injection days, no in-person appointments. Your treatment adapts to your life – not the other way around.
Entirely your business.
The pill looks like any other vitamin. At the office, while travelling, or at home: no one learns of your treatment unless you want them to.
The Wegovy pill is the first approved weight-loss tablet containing the GLP-1 active ingredient semaglutide – the very same compound as in the weekly Wegovy injection. It is taken once daily and comes from the manufacturer Novo Nordisk.
The US Food and Drug Administration (FDA) approved the pill on 22 December 2025 – the first oral GLP-1 medication for weight loss ever.
In the pivotal trial, participants lost an average of 13.6% of their body weight over 64 weeks, and as much as 16.6% with consistent use – comparable to the weekly Wegovy injection.
Always the first to know
Receive an email the moment the weight-loss pill becomes available – along with our newsletter on all things weight loss.
By signing up for the newsletter, I agree to the Terms and Conditions
